Overview
Xiaofeng He practices practicing medicine in Nanjing, China.
Their clinical expertise encompasses Acute Pain, Esophageal Cancer, Lung Adenocarcinoma, and Lung Metastases.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaofeng He
Is Xiaofeng He a top-rated expert for Acute Pain?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaofeng He is classified as an Experienced expert for Acute Pain, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaofeng He participate in research or clinical trials?
Yes. Xiaofeng He has published 15 articles and abstracts on conditions like Acute Pain. You can view a list of Xiaofeng He's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute PainHe isExperienced. Learn about Acute Pain.
- Esophageal CancerHe isExperienced. Learn about Esophageal Cancer.
- Lung AdenocarcinomaHe isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerHe isExperienced. Learn about Lung Cancer.
- Lung MetastasesHe isExperienced. Learn about Lung Metastases.